Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Mindbio Therapeutics Corp. ( (TSE:MBIO) ) has issued an update.
MindBio Therapeutics has deployed a team of software engineers to work with mining and health officials in South America, initially in Chile, to develop protocols for implementing voice-based drug and alcohol screening in the mining sector. The company is accelerating investment in its enterprise voice AI health diagnostics platform, positioning its speech-analytics technology as a scalable, less invasive alternative for high-volume intoxication testing in industries such as mining, aviation and construction, where substance use is linked to a significant share of workplace accidents and represents a substantial market opportunity for its AI platform.
More about Mindbio Therapeutics Corp.
MindBio Therapeutics Corp. is a Vancouver-based biotechnology company focused on drug and alcohol research and AI-driven health prediction technologies. It has developed a voice and AI-powered prediction model that analyzes speech using more than 50 million data points to detect alcohol intoxication, and is expanding the platform to identify other forms of intoxication for use across workplaces, law enforcement, mental health, telehealth, and broader consumer and enterprise settings.
Average Trading Volume: 8,584
Technical Sentiment Signal: Sell
Current Market Cap: C$2.09M
See more insights into MBIO stock on TipRanks’ Stock Analysis page.